Replies to post #266520 on Anavex Life Sciences Corp (AVXL)

[Jimbo50]

Obviously , if decision makers are not privy to data ( and we all agree that they are not) there must be an overwhelming amount of anecdotal ( personal testimonials) out there for shake it up to allocate their finite resources to Anavex. I agree that these developments are positive but the data determines whether the sp sinks or swims

[rayovacAAA]

DISINFORMATION: We know what we know, but there is so much we do not know that others behind the curtain are convinced of!!!!!



FROM DR. CHRISTOPHER MISSLING MS, PhD, MBA


https://seekingalpha.com/article/4344435-anavex-life-sciences-avxl-ceo-christopher-missling-on-q2-2020-results-earnings-call?part=single

Christopher Missling

So the answer to the last question is we would obviously hold a meeting depending on outcome. And regarding the first question, I would rather like to have the data speak for itself, since we don't have any preconceived outcome expectation, since this is the very first study in Parkinson's disease dementia with our drugs. So it's hard for us to formulate any scenario.